Charles E. Chandler

1.3k total citations
21 papers, 1.1k citations indexed

About

Charles E. Chandler is a scholar working on Molecular Biology, Surgery and Cellular and Molecular Neuroscience. According to data from OpenAlex, Charles E. Chandler has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Surgery and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Charles E. Chandler's work include Cholesterol and Lipid Metabolism (6 papers), Nerve injury and regeneration (3 papers) and Natural product bioactivities and synthesis (3 papers). Charles E. Chandler is often cited by papers focused on Cholesterol and Lipid Metabolism (6 papers), Nerve injury and regeneration (3 papers) and Natural product bioactivities and synthesis (3 papers). Charles E. Chandler collaborates with scholars based in United States. Charles E. Chandler's co-authors include Eric M. Shooter, Markus Hosang, Linda M. Parsons, Harvey R. Herschman, H. James Harwood, Stephen F. Petras, John Vincent, George Chang, Lawrence M. Zaccaro and Faan Wen Bangerter and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Journal of Lipid Research.

In The Last Decade

Charles E. Chandler

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles E. Chandler United States 13 449 439 195 173 113 21 1.1k
Chiara Parravicini Italy 20 820 1.8× 266 0.6× 108 0.6× 181 1.0× 48 0.4× 40 1.4k
Brian W. Kimes United States 8 1.1k 2.5× 335 0.8× 98 0.5× 98 0.6× 51 0.5× 10 1.7k
Yan Xia China 20 788 1.8× 532 1.2× 95 0.5× 61 0.4× 45 0.4× 75 1.4k
Marguerite Lucas France 18 710 1.6× 263 0.6× 55 0.3× 67 0.4× 94 0.8× 35 1.1k
J. P. Durkin Canada 19 660 1.5× 219 0.5× 54 0.3× 47 0.3× 38 0.3× 37 1.2k
Saurav Brahmachari United States 20 669 1.5× 463 1.1× 69 0.4× 69 0.4× 45 0.4× 23 1.8k
Yu Pong Ng Hong Kong 16 369 0.8× 227 0.5× 66 0.3× 105 0.6× 17 0.2× 21 871
Heather H. Shih United States 18 931 2.1× 232 0.5× 127 0.7× 107 0.6× 84 0.7× 24 1.7k
Yulia Sidorova Finland 18 379 0.8× 493 1.1× 61 0.3× 153 0.9× 21 0.2× 45 1.0k
William J. Zaks United States 9 989 2.2× 366 0.8× 59 0.3× 73 0.4× 25 0.2× 10 1.3k

Countries citing papers authored by Charles E. Chandler

Since Specialization
Citations

This map shows the geographic impact of Charles E. Chandler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Chandler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Chandler more than expected).

Fields of papers citing papers by Charles E. Chandler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Chandler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Chandler. The network helps show where Charles E. Chandler may publish in the future.

Co-authorship network of co-authors of Charles E. Chandler

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Chandler. A scholar is included among the top collaborators of Charles E. Chandler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Chandler. Charles E. Chandler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chandler, Charles E., et al.. (2003). CP-346086. Journal of Lipid Research. 44(10). 1887–1901. 149 indexed citations
3.
Morehouse, Lee A., Michael P. DeNinno, Philip B. Inskeep, et al.. (1999). Comparison of synthetic saponin cholesterol absorption inhibitors in rabbits: evidence for a non-stoichiometric, intestinal mechanism of action. Journal of Lipid Research. 40(3). 464–474. 58 indexed citations
4.
DeNinno, Michael P., Peter A. McCarthy, John B. Etienne, et al.. (1997). Steroidal Glycoside Cholesterol Absorption Inhibitors. Journal of Medicinal Chemistry. 40(16). 2547–2554. 27 indexed citations
5.
McCarthy, Peter A., Michael P. DeNinno, Lee A. Morehouse, et al.. (1996). 11-Ketotigogenin Cellobioside (Pamaqueside):  A Potent Cholesterol Absorption Inhibitor in the Hamster. Journal of Medicinal Chemistry. 39(10). 1935–1937. 29 indexed citations
6.
McCarthy, Peter A., Michael P. DeNinno, Lee A. Morehouse, et al.. (1994). The discovery of CP-148,623, a potent cholesterol absorption inhibitor in hamsters. Atherosclerosis. 109(1-2). 309–309. 2 indexed citations
7.
Wilkins, Roger, Lawrence M. Zaccaro, Michael P. DeNinno, et al.. (1994). CP-148,623 inhibits cholesterol absorption by preventing cholesterol entry into intestinal mucosa. Atherosclerosis. 109(1-2). 310–310. 3 indexed citations
8.
Zaccaro, Lawrence M., Roger Wilkins, Heidi A. Woody, et al.. (1994). Animal pharmacology of CP-148,623, a cholesterol absorption inhibitor. Atherosclerosis. 109(1-2). 309–310. 3 indexed citations
9.
Morehouse, Lee A., Peter A. McCarthy, R. Gelfand, et al.. (1994). Investigations of the effects of synthetic saponins on cholesterol absorption and serum cholesterol levels. Atherosclerosis. 109(1-2). 88–88. 1 indexed citations
10.
Chandler, Charles E., Lawrence M. Zaccaro, & James B. Moberly. (1993). Transepithelial transport of cholyltaurine by Caco-2 cell monolayers is sodium dependent. American Journal of Physiology-Gastrointestinal and Liver Physiology. 264(6). G1118–G1125. 29 indexed citations
13.
Janesick, James R., et al.. (1990). <title>New advancements in charge-coupled device technology: subelectron noise and 4096 x 4096 pixel CCDs</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 1242. 223–237. 44 indexed citations
14.
Chandler, Charles E., et al.. (1990). <title>Sub-electron noise charge-coupled devices</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 1242. 238–251. 16 indexed citations
15.
Nichols, Robert A., Charles E. Chandler, & Eric M. Shooter. (1989). Enucleation of the rat pheochromocytoma clonal cell line, PC12: Effect on neurite outgrowth. Journal of Cellular Physiology. 141(2). 301–309. 6 indexed citations
16.
Chandler, Charles E., et al.. (1986). Studies of aldose reductase using neuronal cell culture and ligated rat sciatic nerve. Metabolism. 35(4). 71–77. 10 indexed citations
17.
Chandler, Charles E., Edward J. Cragoe, & Luis Glaser. (1985). Nerve growth factor does not activate Na+/H+ exchange in PC12 pheochromocytoma cells. Journal of Cellular Physiology. 125(3). 367–378. 19 indexed citations
18.
Chandler, Charles E., Linda M. Parsons, Markus Hosang, & Eric M. Shooter. (1984). A monoclonal antibody modulates the interaction of nerve growth factor with PC12 cells.. Journal of Biological Chemistry. 259(11). 6882–6889. 466 indexed citations
19.
Chandler, Charles E. & Harvey R. Herschman. (1983). Binding, sequestration, and processing of epidermal growth factor and nerve growth facor by PC12 cells. Journal of Cellular Physiology. 114(3). 321–327. 25 indexed citations
20.
Chandler, Charles E. & Harvey R. Herschman. (1980). Tumor promoter modulation of epidermal growth factor‐ and nerve growth factor‐induced adhesion and growth factor binding of PC‐12 pheochromocytoma cells. Journal of Cellular Physiology. 105(2). 275–285. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026